Gulf International Bank (UK) Ltd - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
Gulf International Bank (UK) Ltd ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$703,000
-48.8%
38,6390.0%0.01%
-47.8%
Q2 2019$1,374,000
+5.9%
38,6390.0%0.02%0.0%
Q1 2019$1,298,000
+2.2%
38,6390.0%0.02%
-8.0%
Q4 2018$1,270,000
-62.2%
38,639
-29.9%
0.02%
-37.5%
Q3 2018$3,361,000
+30.0%
55,139
+4.2%
0.04%
+25.0%
Q2 2018$2,585,00052,9390.03%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders